Cure My Disease

Don't miss your cure!

 Log in / Sign up

Force-Feedback VR put to the test for weak arms after brain bleed

NCT ID NCT07882810

Symptom relief Sponsor: University Medical Centre Maribor Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 20, 2026 · Last updated Oct 21, 2026 · Updated 1 time

Summary

Many people who survive a spontaneous brain bleed keep weakness in an arm or hand. Researchers are testing whether adding haptic virtual reality training, which uses a force-feedback device called Bimeo PRO, to standard physiotherapy and occupational therapy helps recovery. All 100 participants receive ten 60-minute standard therapy sessions over two weeks, and half also do 15 minutes of supervised VR training each session. The study measures arm and hand function, disability, how well people stick with the programme, and side effects to see whether a larger trial is worth doing.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
haptic-assisted virtual reality training using the Bimeo PRO system
What this could lead to
If it helps, this could give stroke rehabilitation teams a practical add-on for arm and hand recovery after a brain bleed.
What could go wrong
This is a small, early-stage study designed to test feasibility, so any benefit may be modest or fade. VR training also requires supervised sessions and suitable equipment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant in the CrossReg-4-Health cohort (age 18 years or older, acute spontaneous non-traumatic intracerebral haemorrhage confirmed by non-contrast CT or MRI) * Residual upper-limb motor impairment * Clinical stability * Ability to participate safely in exercise * Written informed consent for the substudy from the patient or a legally authorised representative Exclusion Criteria: * Intracerebral haemorrhage secondary to head trauma, intracranial neoplasm, isolated subarachnoid haemorrhage or another primary type of intracranial haemorrhage * End-of-life care decision * Withdrawal of consent or major protocol violation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemorrhagic stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemorrhagic stroke intracerebral hemorrhage Paresis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemorrhagic stroke Intracerebral hemorrhage Paresis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Klinikum Klagenfurt am Wörthersee

    Klagenfurt, 9020, Austria

  • LKH-Universitätsklinikum Graz, Medical University of Graz

    Graz, 8036, Austria

  • University Medical Centre Maribor, Department of Neurology

    Maribor, 2000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.